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Abstract
OBJECTIVE: To screen for mRNAs associated with
blood stasis syndrome and to explore the genetic
mechanisms of blood stasis syndrome in hyperten-
sion.
METHODS: This study involved groups of patients
with hypertension and blood stasis, including
those with Qi deficiency, Qi stagnation, cold reten-
tion and heat retention; as well as hypertensive pa-
tients without blood stasis and healthy individuals.
Human umbilical vein endothelial cells were co-cul-
tured with the sera of these healthy individuals and
patients with blood stasis syndrome. Total RNA was
extracted from these cells and assessed by a
high-throughput sequencing method (Solexa) and
digital gene expression. Differentially expressed
genes among these six groups were compared us-
ing whole genome sequences, and mRNAs associat-
ed with blood stasis syndrome identified. Differenc-
es in gene use and gene ontology function were an-
alyzed. Genes enriched significantly and their path-
ways were determined, as were network interac-
tions, and encoded proteins. Gene identities were
confirmed by real-time polymerase chain reactions.
RESULTS: Compared with cells cultured in sera of
the blood stasis groups, those culture in sera of
healthy individuals and of the non-blood stasis
group showed 11 and 301 differences, respectively
in stasis-related genes. Genes identified as differing
between the blood stasis and healthy groups in-
cluded activating transcription factor 4, activating
transcription factor 3, DNA-damage inducible tran-
scription factor 3, Tribbles homolog 3, CCAAT/en-
hancer binding protein-β, and Jun proto-oncogene
(JUN). Pathway and protein interaction network
analyses showed that these genes were associated
with endoplasmic reticulum stress. Cells cultured in
sera of patients with blood stasis and Qi deficiency,
Qi stagnation, heat retention, and cold retention
were compared with cells cultured in sera of pa-
tients with the other types blood stasis syndrome.
The comparison showed differences in expression
of 28, 28, 34, and 32 specific genes, respectively.
CONCLUSION: The pathogenesis of blood stasis
syndrome in hypertension is related to endoplas-
mic reticulum stress and involves the differential ex-
pression of the activating transcription factor 4, ac-
tivating transcription factor 3, DNA-damage induc-
ible transcription factor 3, Tribbles homolog 3,
CCAAT/enhancer binding protein-β, and JUN genes.
© 2016 JTCM. All rights reserved.
Key words: Hypertension; Blood stasis; RNA, mes-
senger; Endoplasmic reticulum stress
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INTRODUCTION
Hypertension is a highly prevalent clinical syndrome
characterized by high arterial pressure that can serious-
ly damage the heart, brain, and kidneys. In traditional
Chinese medicine (TCM), blood stasis is believed to
play an important role in the occurrence and develop-
ment of hypertension. Current studies on the mecha-
nism of blood stasis syndrome have been limited to ob-
serving changes in blood, focusing on the relationship
between vascular changes and the initiation of blood
stasis syndrome. Moreover, blood stasis biology has
been associated with changes in vascular endothelial
cell (VEC) function,1 with VEC damage closely associ-
ated with the initiation and development of blood sta-
sis syndrome.2,3 Endoplasmic reticulum stress (ERS) has
been shown to damage VECs,4 indicating that ERS may
induce blood stasis by causing endothelial cell injury.
Our research group has focused on a blood stasis syn-
drome model, including the effects of VEC injury and
mechanisms of repair, as well as on the effects of drugs
and the molecular / genetic mechanisms underlying
blood stasis. We and others have found that different
types of blood stasis have different biochemical founda-
tions, but also have common pathological and physio-
logical characteristics.5-10 Because of the complex patho-
genesis of blood stasis syndrome, including the effects
of various factors, screening for and identifying bio-
markers associated with this syndrome may help in its
diagnosis and treatment. An established model of endo-
thelial cell injury-blood stasis syndrome was used to
screen for genes associated with the initiation of hyper-
tension-related blood stasis syndrome among groups of
hypertensive patients, with and without blood stasis
syndrome, and healthy individuals. The genetic path-
ways of identified genes were investigated to determine
the molecular mechanism underlying the development
of blood stasis syndrome in hypertension.
MATERIALS ANDMETHODS
Three groups of individuals were analyzed. The first
group included 40 patients (21 males, 19 females), of
mean age (66 ± 7) years, diagnosed with blood stasis
syndrome with hypertension from December 2011 to
June 2012 at the Second Hospital affiliated with
Guangzhou Medical College. Their mean systolic and
diastolic blood pressures were (157 ± 13) and (104 ± 7)
mm Hg, respectively. TCM syndrome differentiation
rules have identified four types of patients with blood
stasis syndrome plus hypertension: blood stasis syn-
drome with Qi deficiency, Qi stagnation, cold reten-
tion, and heat retention. Ten patients were included in
each subgroup.
Another group of 12 patients [6 males, 6 females, of
mean age (65 ± 9) years] had hypertension but without
blood stasis. Their mean systolic and diastolic b; ppd
pressures were (166 ± 8) and (104 ± 8) mm Hg, respec-
tively. These patients were recruited from the cardiovas-
cular department, the outpatient TCM department,
and patients hospitalized at the First Affiliated Hospi-
tal of Jinan University. Patients in this group did not
differ significantly from the group of hypertensive pa-
tients with blood stasis syndrome in blood pressure, sex
distribution, mean arterial pressure, or average age
(each P > 0.05).
The third group consisted of 30 healthy volunteers (17
males, 13 females), recruited from the Department of
Traditional Chinese Medicine, School of Medicine, Ji-
nan University. Their blood pressures were within nor-
mal ranges and differed significantly (P < 0.01) from
blood pressures in hypertensive patients, both with and
without blood stasis syndrome.
High blood pressure was defined according to World
Health Organization / International Hypertension Alli-
ance guidelines (1999),11 and blood stasis syndrome
was diagnosed according to the 2011 revised criteria.12
Patients with target organ damage, diabetes, or severe
cardiovascular, cerebrovascular, or renal disease were ex-
cluded.
Serum collection
All included individuals were instructed to fast and not
take any drugs overnight prior to a blood draw. Fore-
arm venous blood was aseptically collected into sterile,
non-anticoagulation vacuum tubes, allowed to coagu-
late, and centrifuged at 2784´g at 4 ℃ for 15 min. Se-
rum was removed, placed in an aseptic Eppendorf tube
(Gibco, Guangzhou, China), and incubated in a water
bath at 56 ℃ for 30 min to inactivate serum comple-
ment. Finally, these samples were stored at－20℃.
Establishing a cell model
The cell model of hypertension and blood stasis,13 in-
volved the use of human umbilical vascular endothelial
cells (HUVECs; CRL-1730), obtained from the Ameri-
can Type Culture Collection (ATCC; Manassas, VA,
USA). These cells were cultured in Dulbecco's Modi-
fied Eagle's medium (DMEM); (Gibco) containing
10% fetal bovine serum at 37 ℃ in a 5% CO2 incuba-
tor. To each culture flask was added serum, to a concen-
tration of 10%, plus 90% F12K medium (Gibco), and
the cells were cultured at 37 ℃ in a 5% CO2 incubator
for 24 h.
The cells were collected, and total RNA was extracted
with Trizol (Invitrogen, Carlsbad, CA, USA). RNA
quality was assessed by agarose gel electrophoresis.
mRNA sequence analysis and gene screening
mRNA transcriptome sequencing was performed using
second-generation IIlimina Solexa sequencing technolo-
gy by the Shanghai Megiddo Biotechnology Co., Ltd.
(Shanghai, China), The original statistical data were as-
sessed while retaining high-quality sequences. Statisti-
cal analyses of each fragment per kilobase of exons per
million fragments mapped (FPKM), as well as the tran-
script value in the expressed samples, were compared.
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Finally, differences in group transcripts and relative
gene expression were analyzed among the six groups of
samples.
Gene function analysis
Differentially expressed genes were analyzed using
Goatools (https: //github.com/tanghaibao/GOatools)
in the GO database, along with a PATHWAY enrich-
ment analysis of differential gene use with the software
KO-Based Annotation System (KOBAS) (http: //kobas.
cbi.pku.edu.cn/home.do). False positive rates were
compared by Fisher's exact tests. A P value ≤ 0.05 was
considered significant.
Differences in the expression of significantly enriched
genes in the Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) were used to identify cellular path-
ways. The Human Protein Reference Database (http: //
www.hprd.org/Release 9), was used to assess interac-
tions among these genes and interaction data were de-
termined using Cytoscape software (http://www.cyto-
scape.org/) for network visualization.
Quantitative real-time polymerase chain reaction
(qRT-PCR)
PCRs were performed according to the manufacturer's
instructions, with primers designed based on the se-
quences in the gene database. The2-ΔΔCT method was
used to assess differential gene expression. Log2 ratios
were determined by comparing gene expression in the
five hypertensive groups with that in healthy controls.
RESULTS
RNA extraction
Total RNA was extracted from HUVECs incubated
with serum from each of the groups of subjects. The
28S and 18S rRNA bands were clear, with no observed
residue at the dye front. The ratio of A260 to A280
was 1.8-2, showing that the quality of these total RNA
samples was in full compliance with requirements for
chip analysis.
Differential gene expression of blood stasis syndrome
Gene expression by each cell sample was assessed by dif-
ferential gene expression (DGE) analysis, with a P val-
ue of < 0.01, an False Discovery Rate (FDR) of <
0.001, and a |log2Ratio| of ≥ 1 considered significant
(Figure 1). The four groups with hypertension and
blood stasis groups showed significant differences in
mRNA expression compared with the control group.
Specifically, the groups with Qi deficiency, Qi stagna-
tion, cold retention, and heat retention showed signifi-
cant differences in 76 (42 downregulated and 34 upreg-
ulated), 51 (34 downregulated and 17 upregulated), 61
(39 downregulated and 22 upregulated) and 62 (39
downregulated and 23 upregulated) mRNAs, respec-
tively. The four groups with hypertension and blood
stasis also showed significant differences compared
with the group with hypertension but without blood
stasis. Specifically, the groups with Qi deficiency, Qi
stagnation, cold retention, and heat retention showed
significant differences in 579 (117 downregulated and
459 upregulated), 475 (98 downregulated and 337 up-
regulated), 621 (135 downregulated and 486 upregulat-
ed) and 469 (103 downregulated and 366 upregulated)
mRNAs, respectively. In addition, the group with hy-
pertension but without blood stasis differed from the
healthy group in 529 (423 downregulated and 106 up-
regulated) mRNAs.
Differential mRNA expression analysis
Integrated analyses of differential mRNA expression in
the six groups are shown in Table 1.
Figure 1 Numbers of mRNAs differentially expressed between pairs of groups
QDBS: Qi deficiency and blood stasis; QSBS: Qi stagnation and blood stasis; CBS: cold retention and blood stasis; HBS: heat reten-
tion and blood stasis; NBS: hypertension without blood stasis; NC: healthy controls. Compare with NC group, the groups with QD-
BS, QSBS, CBS, and HBS showed significant differences in 76 (42 downregulated and 34 upregulated), 51 (34 downregulated and
17 upregulated), 61 (39 downregulated and 22 upregulated) and 62 (39 downregulated and 23 upregulated) mRNAs, respective-
ly. Compared with NBS group, the groups with QDBS, QSBS, CBS, and HBS showed significant differences in 579 (117 downregu-
lated and 459 upregulated), 475 (98 downregulated and 337 upregulated), 621 (135 downregulated and 486 upregulated) and
469 (103 downregulated and 366 upregulated) mRNAs, respectively. In addition, the group with NBS differed from NC group in
529 (423 downregulated and 106 upregulated) mRNAs.
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GO enrichment analysis of differentially expressed
genes in different blood stasis syndromes
Patients with blood stasis and heat retention, cold re-
tention, Qi deficiency, and Qi stagnation were com-
pared with the group with hypertension but without
blood stasis. GO enrichment analysis demonstrated
that differentially expressed genes are related to multi-
ple stress responses, cell differentiation, apoptosis, and
autophagy in VECs. These genes are also immune relat-
ed (P < 0.05) (Figure 2). Five of the 20 pathways iden-
tified were directly associated with endoplasmic reticu-
lum stress (ERS), including PERK-regulated gene ex-
pression, chaperone activation of IRE1alpha, chaper-
one activation by activating transcriptional factor 6
(ATF6)-alpha, and the release of eIF4E and the ATF-2
transcription factor network. Other pathways included
the interleukin (IL)-6 and IL-2 inflammatory path-
ways, the p53 and p38 apoptosis pathways, the mam-
malian target of rapamycin (mTOR) and vascular en-
dothelial growth factor (VEGF) pathways, the mito-
gen-activated protein kinase (MAPK) signaling path-
way, and signal transduction and amino acid metabo-
lism pathways (Table 2).
Protein expression and blood stasis syndrome
Comparisons of gene expression by cells incubated
with sera from patients with hypertension alone and
those with hypertension and blood stasis revealed evi-
dence of differential expression of specific genes in pro-
tein networks. Genes associated with ERS included ac-
tivating transcription factor 4 (ATF4), activating tran-
scription factor 3 (ATF3), DNA-damage inducible
transcription factor 3 (DDIT3), Tribbles homolog 3
(TRIB3), CCAAT / enhancer binding protein-β (CEB-
PB), JUN, Jun dimerization protein 2 and Early
growth response 1 (Figure 3).
Confirmation of differential mRNA expression by
qRT-PCR
qRT-PCR analysis comparing mRNA expression in the
four groups with hypertension and blood stasis syn-
drome and the group with hypertension alone and the
control group confirmed findings on the differential ex-
pression of ATF4, ATF3, DDIT3, TRIB3, CEBPB,
and JUN mRNAs (Figure 4).
DISCUSSION
Hypertension is a polygenic disease resulting from dif-
ferent genetic and environmental factors14 and can en-
hance the risk of cardiac and cerebrovascular diseases.
Hypertensive patients with blood stasis syndrome show
increases in hemorheology, hemodynamics, and micro-
circulation.15 ERS can damage VECs by promoting the
expression of p38 mitogen activated protein kinase
(MAPK) and its downstream molecules, along with oxi-
dative stress. These findings suggest that ERS may be
caused by endothelial cell injury resulting from blood
stasis, consistent with results showing that ERS inhibi-
tion is effective in treating vascular-related diseases.16
The ER is important for protein synthesis and folding,
Ca2+ storage, and lipid synthesis.17 Modifications of se-
creted, transmembrane, and ER resident proteins can
help them fold into their native conformations, eventu-
ally forming functional proteins.18 Changes in the in-
ner cellular environment, such as hypoxia, Ca2+ homeo-
stasis, oxidative stress, or abnormal glycosylation, can
result in the accumulation of unfolded or misfolded
proteins in the ER, resulting in ER dysfunction or
ERS. Protein accumulation leads to a series of fol-
low-up reactions, called an unfolded protein response
(UPR). Reducing the amount of protein in the ER re-
Group
Qi deficiency and blood stasis syndrome vs normal and vs hypertension alone
Qi stagnation and blood stasis syndrome vs normal and vs hypertension alone
cold retention and blood stasis syndrome vs normal and vs hypertension alone
heat retention and blood stasis syndrome vs normal and vs hypertension alone
All four groups with blood stasis syndrome vs hypertension alone
All four groups with blood stasis syndrome vs normal
Qi deficiency and blood stasis syndrome in endemic hypertension
Qi stagnation and blood stasis syndrome in endemic hypertension
cold retention and blood stasis syndrome in endemic hypertension
Heat retention and blood stasis syndrome in endemic hypertension
Qi deficiency and blood stasis syndrome
Qi stagnation and blood stasis syndrome
cold retention and blood stasis syndrome
heat retention and blood stasis syndrome
Total
22
19
14
14
301
11
28
28
32
34
124
81
161
69
mRNA Difference
Upregulated
10
11
7
7
239
2
14
8
10
9
67
34
83
38
Downregulated
12
8
7
7
62
9
14
20
22
25
57
47
78
31
Table 1 Specific gene statistics in blood stasis syndrome
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sults in the repair of misfolded proteins and the degra-
dation of unfolded and misfolded proteins in the ER,
restoring ER function and ensuring the release of ma-
ture proteins. Overexposure to the altered cellular in-
volvement may overwhelm UPR capacity, leading to
apoptosis.19-24 Stress and UPR can activate three tran-
scription factors, inositol enzyme (IRE-1), pancreatic
endoplasmic protein kinase (PERK), and activating
transcription factor 6 (ATF6), resulting in three steps
to induce cell apoptosis, involving PERK, ATF4, and
the phosphorylation of eukaryotic translation initiation
factor 2α (eIF2α).25 PERK pathway activation occurs
by inhibiting protein during early ERS, resulting in the
phosphorylation of elF2α and ATF4 activation; this in
turn promotes the activation and expression of
CCAAT-enhancer-binding protein homologous pro-
tein (CHOP) and induces cell apoptosis.26
ATF4 is a key molecule increased in ERS-induced
apoptosis.27 The transcription factor CEBPB is in-
volved in many biological processes, including cell dif-
ferentiation, proliferation, metabolism, tumors, inflam-
mation, and apoptosis. The C/EBP homologous pro-
tein CHOP is an important signaling molecule in the
ERS-associated apoptosis pathway.28 DDIT3, also
known as GADD153, CHOP, and C / EBP, is a mem-
ber of the C / EBP family of transcription factors. Its
high expression may affect protein folding in the ER
and trigger an unfolded protein response and apoptosis
induced by a specific ER cell pathway network, causing
cell death. This protein plays an important role in in-
duced cell cycle arrest, promoting cell differentiation
and apoptosis.29 ATF3 is a member of the ATF/CERB
transcription factor family that inhibits transcription
by binding to the gadd153 / CHOP promoter and cor-
responding sites. ATF3 plays an important role in the
transcriptional regulation of cell apoptosis, with any
factor that upregulates ATF3 expression inducing cell
apoptosis.30 The v-Jun sarcoma virus 17 gene homo-
logue JUN binds to the promoter regions of many
genes, regulating the expression of many genes in vari-
ous malignant tumors. TRIB3 is a serine/threonine pro-
tein kinase and a member of a newly discovered pro-
tein gene family that can inhibit mitosis. Overexpres-
sion of TRIB3 can inhibit the MAPK pathway, adjust
the NF-κB pathway, and induce apoptosis.31 Thus, all
of these genes and ERS are closely related to cell apop-
tosis.
Our results, using gene chip technology, showed differ-
ences in mRNA expression among patients with hyper-
tension plus blood stasis, hypertension alone, and nor-
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Primary metabolic process
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Figure 2 GO gene protein analysis related to blood stasis syndrome
A: Biological processes; B: molecular functions, C: cellular components. The ordinate indicates significant enrichment using the
GO term; the abscissa represents the enrichment factor; GO: gene ontology.
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mal controls. ATF4, ATF3, DDIT3, TRIB3, CEBPB,
and JUN mRNAs were more highly expressed in the
blood stasis groups. GO and PATHWAY analysis
showed that multiple genes and a signal pathway were
Table 2 Identification of gene pathways and involved genes differentiating patients with hypertension plus blood stasis syn-
drome and those with hypertension alone
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Pathway
PERK regulated gene expression
Amino acid and oligopeptide SLC transporters
Activation of Chaperones by IRE1alpha
Amino acid transport across the plasma membrane
Serine biosynthesis
Signaling mediated by p38-alpha and p38-beta
IL6-mediated signaling
Axonal growth stimulation
Activation of Chaperones by ATF6-alpha
p53 signaling pathway
Vitamin B6 metabolism
Release of eIF4E
Disease
mTOR signaling pathway
ATF-2 transcription factor network
IL12 and STAT4 dependent signaling pathways in Th1 development
Neurophilin interactions with VEGF and VEGFR
Circadian clock
VEGF signaling pathway
MAPK signaling pathway
Number of genes
5
8
4
6
3
5
7
2
2
7
2
2
16
5
6
3
2
3
4
9
Background gene number
45
341
51
190
23
343
349
18
26
691
42
57
4993
553
494
103
28
210
693
2468
Notes: PERK: pancreatic endoplasmic reticulum kinase; SLC: solute-carrier; IRE1: inositol-requiring protein 1; IL-6: interleukin-6; ATF6:
activating transcriptional factor 6; eIF4E: eukaryotic initiation factor 4E; mTOR: mammalian target of rapamycin; ATF2: activating tran-
scription factor-2; IL-12: interleukin-12; VEGF: vascular endothelial growth factor; VEGFR: vascular endothelial growth factor receptor;
MAPK: mitogenactivated protein kinase.
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Figure 3 Correlations between blood stasis and gene expression network interactions
A: Qi stagnation and blood stasis (QSBS) vs hypertension without blood stasis (NBS); B: Qi deficiency and blood stasis (QDBS) vs
NBS; C: cold retention and blood stasis (CBS) vsNBS; D: heat retention and blood stasis (HBS) vs NBS. ATF4: activating transcription
factor 4; ATF3: activating transcription factor 3; JUN: Jun proto-oncogene; CEBPB: CCAAT/enhancer binding protein-β; DDIT3:
DNA-damage inducible transcription factor 3; TRIB3: Tribbles homolog 3; CEBPG: CCAAT/enhancer binding protein gamma;
TSC22D3: TSC22 domain family member 3; JDP2: Jun dimerization protein 2; MYC: v-myc avian myelocytomatosis viral oncogene
homolog ; RASSF1: Ras association (Ral GDS/AF-6) domily member 1; EGR1: Early growth response 1.
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related to ERS. Determining the relationships of
ATF4, ATF3, DDIT3, TRIB3, CEBPB, and JUN, as
well as of ERS, with the pathogenesis of blood stasis in
hypertension requires additional in vitro and in vivo
studies.
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